Australian National Enterovirus Reference Laboratory annual report, 2023
DOI:
https://doi.org/10.33321/cdi.2025.49.013Keywords:
poliovirus, acute flaccid paralysis, surveillance, enterovirus, poliomyelitis, eradication, vaccinationAbstract
Australia monitors its polio-free status by conducting surveillance for cases of acute flaccid paralysis (AFP) in children less than 15 years of age, as recommended by the World Health Organization (WHO). Cases of AFP in children are notified to the Australian Paediatric Surveillance Unit or the Paediatric Active Enhanced Disease Surveillance System and faecal specimens are referred for virological investigation to the National Enterovirus Reference Laboratory. In 2023, no cases of poliomyelitis were reported from clinical surveillance and Australia reported 1.71 non-polio AFP cases per 100,000 children, thereby meeting the WHO’s performance criterion for a sensitive surveillance system. The non-polio enteroviruses coxsackievirus A9, coxsackievirus B5, echovirus 9, echovirus 30, enterovirus A71 and enterovirus C96 were identified from clinical specimens collected from AFP cases. Australia also performs enterovirus and wastewater surveillance to complement the clinical system focussed on children. In 2023, there were twelve cases of wild poliovirus reported from the last two remaining endemic countries: Afghanistan and Pakistan. Another 23 countries reported cases of poliomyelitis due to circulating vaccine-derived poliovirus.
Downloads
References
Aylward RB. Poliomyelitis. In Heymann DL, ed. Control of Communicable Diseases Manual. 20th ed. Fort Worth: APHA Press, 2015;477–84. doi: https://doi.org/10.2105/CCDM.2745.116.
Nathanson N, Kew OM. From emergence to eradication: the epidemiology of poliomyelitis deconstructed. Am J Epidemiol. 2010;172(11):1213–29. doi: https://doi.org/10.1093/aje/kwq320.
World Health Organization (WHO). Poliomyelitis. [Internet.] Geneva: WHO; 24 October 2023. [Accessed on 26 March 2024.] Available from: https://www.who.int/news-room/fact-sheets/detail/poliomyelitis.
Adams T. Farewell to polio in the Western Pacific. Bull World Health Organ. 2000;78(12):1375.
Australian Paediatric Surveillance Unit (APSU). Study Protocol: Acute Flaccid Paralysis. [Internet.] Sydney: APSU; 2024. [Accessed on 26 March 2024.] Available from: https://www.apsu.org.au/assets/current-studies/AFP-Study-Protocol-June-2.pdf.
Paediatric Active Enhanced Disease Surveillance (PAEDS). Surveillance and research: acute flaccid paralysis. [Internet.] Sydney: National Centre for Immunisation Research and Surveillance, PAEDS; 2022. [Accessed on 26 April 2024.] Available from: http://www.paeds.org.au/our-work/surveillance-and-research.
Puenpa J, Wanlapakorn N, Vongpunsawad S, Poovorawan Y. The history of enterovirus A71 outbreaks and molecular epidemiology in the Asia-Pacific region. J Biomed Sci. 2019;26(1):75. doi: https://doi.org/10.1186/s12929-019-0573-2.
Sun J, Hu XY, Yu XF. Current understanding of human enterovirus D68. Viruses. 2019;11(6):490. doi: https://doi.org/10.3390/v11060490.
WHO. Polio and Prevention. The Virus. [Internet.] Geneva: WHO; 7 October 2016. [Accessed: 26 March 2024.] Available from: https://polioeradication.org/polio-today/polio-prevention/the-virus/.
WHO. Global wild poliovirus 2018-2024. Geneva: WHO; 26 March 2024. [Accessed on 26 March 2024.] Available from: https://polioeradication.org/wp-content/uploads/2024/03/weekly-polio-analyses-WPV-20240326.pdf.
WHO. Statement of the thirty-fifth Polio IHR Emergency Committee. [Internet.] Geneva: WHO; 12 May 2023. [Accessed on 26 March 2024.] Available from: https://www.who.int/news/item/12-05-2023-statement-of-the-thirty-fifth-polio-ihr-emergency-committee.
WHO. Global circulating vaccine-derived poliovirus. [Internet.] Geneva: WHO; 26 March 2024. [Accessed on 26 March 2024.] Available from: https://polioeradication.org/this-week/variant-polio-cvdpv-cases/.
Australian Government Department of Health and Aged Care. Poliovirus infection. [Internet.] Canberra: Australian Government Department of Health and Aged Care; 12 July 2022. [Accessed on 26 March 2024.] Available from: http://www.health.gov.au/diseases/poliovirus-infection.
Queensland Government Department of Health (Queensland Health). Acute flaccid paralysis (AFP). [Internet.] Brisbane: Queensland Health; 20 July 2022. [Accessed on 26 March 2024.] Available from: https://www.health.qld.gov.au/disease-control/conditions/acute-flaccid-paralysis-afp.
APSU. Current Studies. Acute Flaccid Paralysis (AFP). [Internet.] Sydney: APSU; 2024. [Accessed on 26 March 2024.] Available from: https://apsu.org.au/studies/current/#acute-flaccid-paralysis.
WHO. Polio: Vaccine Preventable Diseases Surveillance Standards. Geneva: WHO; 4 September 2018. [Accessed on 26 March 2024] Available from: https://www.who.int/publications/m/item/vaccine-preventable-diseases-surveillance-standards-polio.
WHO. Weekly epidemiological record (WER). Geneva: WHO; 22 March 2024. [Accessed on 26 March 2024] Available from: https://iris.who.int/handle/10665/376320.
Wood DJ, Hull B. L20B cells simplify culture of polioviruses from clinical samples. J Med Virol. 1999;58(2);188–92. doi: https://doi.org/10.1002/(SICI)1096-9071(199906)58:2<188::AID-JMV15>3.0.CO;2-H.
WHO. Polio Laboratory Manual, 4th edition. (WHO/IVB/04.10) Geneva: WHO, Department of Immunization, Vaccines and Biologicals; 2004.
Sun H, Harrington C, Gerloff N, Mandelbaum M, Jeffries-Miles S, Apostol LNG et al Validation of a redesigned pan-poliovirus assay and real-time PCR platforms for the global poliovirus laboratory network. PloS One. 2021;16(8):e0255795. doi: https://doi.org/10.1371/journal.pone.0255795.
Stewardson AJ, Roberts JA, Beckett CL, Prime HT, Loh PS, Thorley BR et al. Imported case of poliomyelitis, Melbourne, Australia, 2007. Emerg Infect Dis. 2009;15(1):63–5. doi: https://doi.org/10.3201/eid1501.080791.
WHO. Guidelines for environmental surveillance of poliovirus circulation. Geneva: WHO, Department of Vaccines and Biologicals; 2003. Available from: https://iris.who.int/handle/10665/67854.
Roberts JA. Thesis. “Chapter 2: Development of a Novel Enterovirus Detection and Super-Speciation Assay”, An integrated bioinformatics and computational biophysics approach to enterovirus surveillance and research. RMIT University, 2014: 62-109. [Accessed on 26 April 2024.] Available from: https://researchbank.rmit.edu.au/view/rmit:162129.
Venkatesan P. Global polio eradication set back by COVID-19 pandemic. Lancet Microbe. 2022:3(3):e172. doi: https://doi.org/10.1016/S2666-5247(22)00042-8.
Raphael M, Adam DC, Chughtai AA, Kelly-Hanku A, Hutchinson D, Lai YA et al. Poliomyelitis outbreak in Papua New Guinea, 2018. Global Biosecurity. 2022;4(1). doi: https://doi.org/10.31646/gbio.164.
Snider CJ, Boualam L, Tallis G, Takashima Y, Abeyasinghe R, Lo YR et al. Concurrent outbreaks of circulating vaccine-derived poliovirus types 1 and 2 affecting the Republic of the Philippines and Malaysia, 2019–2021. Vaccine. 2023;41(Suppl 1):A58–69. doi: https:doi.org/10.1016/j.vaccine.2022.02.022.
WHO. Disease Outbreak News: Circulating vaccine-derived poliovirus type 2 (cVDPV2) – Indonesia. [Internet.] Geneva: WHO; 11 January 2024. [Accessed on 26 March 2024.] Available from: https://www.who.int/emergencies/disease-outbreak-news/item/2024-DON500.
May M, Durrheim D, Roberts JA, Owen R. The risks of medical complacency towards poliomyelitis. Med J Aust. 2020;213(2):61–3. doi: https://doi.org/10.5694/mja2.50681.
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2025 Communicable Diseases Intelligence
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
